Detalles de la búsqueda
1.
TP53 DNA binding domain mutational status and rituximab-based treatment are independent prognostic factors for pediatric Burkitt lymphoma patients stratification.
Haematologica
; 2024 Feb 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38385281
2.
Quantitative assessment of minimal residual disease for monitoring of paediatric patients with relapsed/refractory anaplastic large-cell lymphoma treated with brentuximab vedotin: A case series.
Br J Haematol
; 204(1): 352-355, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37822050
Resultados
1 -
2
de 2
1
Próxima >
>>